Europe — EMA
Palonosetron Accord
Palonosetron, the active ingredient in Palonosetron Accord, is a 5-HT3 receptor antagonist presented as a 0.075 mg/1 ml solution for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Accord, is a 5-HT3 receptor antagonist presented as a 0.075 mg/1 ml solution for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy and postoperative recovery in adult patients. GNH USA supplies Palonosetron Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
GNH USA supplies Palonosetron Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Palonosetron used for?
Palonosetron Accord acts by target the specific h ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
- Chemotherapy‑induced nausea and vomiting (CINV): Provides … ... ... ... ... ... ... ... ... ... ... ... """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""."
